Cyclacel pharmaceuticals to participate in 2024 bio ceo & investor conference

Berkeley heights, n.j., feb. 20, 2024 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that spiro rombotis, president and chief executive officer, is scheduled to present at the 2024 bio ceo & investor conference taking place in-person at the new york marriott marquis on february 26-27, 2024.
CYCC Ratings Summary
CYCC Quant Ranking